Results 11 to 20 of about 3,725 (244)

Dihydroxyphenylalanine-conjugated high molecular weight polyethylenimine for targeted delivery of Plasmid

open access: yesScientific Reports
High molecular weight polyethylenimine (HMW PEI; branched 25 kDa PEI) has been widely investigated for gene delivery due to its high transfection efficiency.
Zahra Taheri   +6 more
doaj   +2 more sources

L-3,4-dihydroxyphenylalanine Accumulation in Faba Bean (Vicia faba L.) Tissues during Different Growth Stages

open access: yesAgronomy, 2021
L-3,4-dihydroxyphenylalanine (L-dopa)-rich faba (Vicia faba L.) tissues are a potentially useful source for its pharmaceutical purpose, although the species contains health curious vicine and convicine in the seeds.
Shucheng Duan   +5 more
doaj   +1 more source

Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate

open access: yesJournal of Pharmacological Sciences, 2023
Methylphenidate (MPH) and methamphetamine (METH) are the current treatments of choice for attention deficit/hyperactivity disorder. We previously reported that METH induces the release of dopamine (DA) and of the neurotransmitter candidate L-3,4 ...
Hiraku Uchimura   +6 more
doaj   +1 more source

Biomedical and Clinical Importance of Mussel-Inspired Polymers and Materials

open access: yesMarine Drugs, 2015
The substance secreted by mussels, also known as nature’s glue, is a type of liquid protein that hardens rapidly into a solid water-resistant adhesive material.
Nagendra Kumar Kaushik   +5 more
doaj   +1 more source

l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice

open access: yesJournal of Pharmacological Sciences, 2016
Through its conversion to dopamine by aromatic l-amino acid decarboxylase (AADC), l-3,4-dihydroxyphenylalanine (l-DOPA) replenishes depleted brain dopamine in Parkinson's disease patients. We recently identified GPR143 as a candidate receptor for l-DOPA.
Suguru Ueda   +3 more
doaj   +1 more source

Effects of Aging on Levo-Dihydroxyphenylalanine- Induced Dyskinesia in a Rat Model of Parkinson’s Disease

open access: yesFrontiers in Aging Neuroscience, 2021
BackgroundIt remains unclear why patients with young-onset Parkinson’s disease more often develop levo-dihydroxyphenylalanine (L-dopa)-induced dyskinesia (LID) and have a more severe form than patients with old-onset Parkinson’s disease. Previous studies
Haruo Nishijima   +8 more
doaj   +1 more source

Effect of Selective Serotonin Reuptake Inhibitors via 5-HT1A Receptors on L-DOPA-Induced Rotational Behavior in a Hemiparkinsonian Rat Model

open access: yesJournal of Pharmacological Sciences, 2012
l-Dihydroxyphenylalanine (l-DOPA) is considered the gold standard for the treatment of Parkinson’s disease (PD). However, long-term administration of l-DOPA can induce abnormal side effects.
Masatoshi Inden   +6 more
doaj   +1 more source

Synthesis of Novel Chiral L-Phenylalanine Grafted PEDOT Derivatives with Electrochemical Chiral Sensor for 3,4-Dihydroxyphenylalanine Discrimination

open access: yesInternational Journal of Electrochemical Science, 2015
Two amino-functionalized chiral poly(3,4-ethylenedioxythiophene) (PEDOT) derivatives, poly(N-(tert-butoxycarbonyl)-L-phenylalayl (3,4-ethylenedioxythiophene-2'-yl)methylamide) (PEDOT-Boc-Phe) and poly(L-phenylalayl (3,4-ethylenedioxythiophene-2'-yl ...
Dufen Hu   +9 more
doaj   +1 more source

Genetic associations of single nucleotide polymorphisms in the l-DOPA receptor (GPR143) gene with severity of nicotine dependence in Japanese individuals, and attenuation of nicotine reinforcement in Gpr143 gene-deficient mice

open access: yesJournal of Pharmacological Sciences, 2020
l-3,4-dihydroxyphenylalanine (l-DOPA) is a candidate neurotransmitter. l-DOPA is released by nicotine through nicotinic receptors. Recently, G-protein coupled receptor GPR143, was identified as a receptor for l-DOPA.
Daiki Masukawa   +13 more
doaj   +1 more source

Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]

open access: yesDrug, Healthcare and Patient Safety, 2020
Hinz M, Stein A, Cole T. Drug Healthc Patient Saf.  2014;6:93— 99. The Editor-in-chief and Publisher of Drug, Healthcare and Patient Safety wish to retract the published article.
Hinz M, Stein A, Cole T
doaj  

Home - About - Disclaimer - Privacy